Conversely, other miRNAs expression is specifically disturbed in each disease; for instance, the targeting ability of miR-421 on SIRT3 and miR-200a on Keap1/Nrf2 suggests that normalizing their expression might grant protection against OS-induced damage in NAFLD. The gene discussed is KEAP1; the disease is metabolic dysfunction-associated steatotic liver disease.